Twist Bioscience Corporation (0ME)
XDUS
Delayed Data
Oct 20, 2026, 06:00 AM
Day's Range
123.1052 wk Range
21.11Overview - 0ME - Twist Bioscience Corporation
Key Statistics
Valuation
Enterprise Value
-107.47M
P/E (Trailing)
‪-108.42‬
PEG Ratio
‪0.40‬
Price / Book
‪19.73‬
EV / EBITDA
‪0.67‬
Profitability
Gross Margin
‪52.75%‬
Profit Margin
‪50.72%‬
Operating Margin
‪-36.18%‬
Return on Assets
‪-12.10%‬
Return on Equity
‪-16.42%‬
Ownership
Shares Outstanding
62.67M
Price stats
50-Day Avg
‪116.98‬
200-Day Avg
‪67.32‬
Peers - 0ME - Twist Bioscience Corporation
Peer Comparison
Compared with companies in Biotechnology listed on XDUS.
- 0MEXDUSTwist Bioscience Corporation+80.08%52-week change-108.42P/E (Trailing)‪50.72%‬Profit Margin
- 0QFXDUSModerna Inc.+88.57%52-week change—P/E (Trailing)—Profit Margin
- 2LBXDUSIovance Biotherapeutics Inc.+83.47%52-week change-10.55P/E (Trailing)‪34.27%‬Profit Margin
- 3920XDUSSpyre Therapeutics, Inc.+76.32%52-week change-38.38P/E (Trailing)—Profit Margin
- 42ZXDUSRevolution Medicines, Inc.+75.52%52-week change-28.70P/E (Trailing)—Profit Margin
- 26CAXDUSImmunityBio Inc.+74.71%52-week change-22.00P/E (Trailing)‪99.33%‬Profit Margin
- 7BGXDUSOncoinvent ASA+72.12%52-week change-0.05P/E (Trailing)—Profit Margin
Profile Summary - 0ME - Twist Bioscience Corporation
About
Twist Bioscience Corporation is a synthetic biology company that develops and sells DNA-based products for research and commercial applications. Twist Bioscience Corporation’s portfolio includes synthetic genes, gene fragments, oligonucleotide pools, and antibody libraries used in therapeutic discovery, diagnostics,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
